{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T20:10:03Z","timestamp":1744402203933,"version":"3.40.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA058700"],"award-info":[{"award-number":["R01DA058700"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cbi.2025.111491","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:33:08Z","timestamp":1743265988000},"page":"111491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of bromodomain and extra-terminal (BET) proteins with JQ1 exacerbates acetaminophen-induced hepatotoxicity by altering detoxification pathways and oxidative stress responses"],"prefix":"10.1016","volume":"413","author":[{"given":"A.P.","family":"Laddha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Seyednejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Donepudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Goedken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Manautou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-1830","authenticated-orcid":false,"given":"G.C.","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111491_bib1","unstructured":"Acetaminophen Toxicity - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/28722946\/(accessed October 25, 2024)."},{"key":"10.1016\/j.cbi.2025.111491_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of acetaminophen-induced liver necrosis","volume":"196","author":"Hinson","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111491_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116056","article-title":"Clinically relevant therapeutic approaches against acetaminophen hepatotoxicity and acute liver failure","volume":"228","author":"Ramachandran","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111491_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp700114j","article-title":"Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity","volume":"5","author":"Cheng","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2025.111491_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/toxsci\/59.1.169","article-title":"High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes","volume":"59","author":"Enomoto","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2025.111491_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2005.10.185","article-title":"Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity","volume":"339","author":"Okawa","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2025.111491_bib7","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1124\/dmd.114.059006","article-title":"Is nuclear factor erythroid 2-related factor 2 responsible for sex differences in susceptibility to acetaminophen-induced hepatotoxicity in mice?","volume":"42","author":"Rohrer","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2025.111491_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5487\/TR.2013.29.3.165","article-title":"Recent updates on acetaminophen hepatotoxicity: the role of nrf2 in hepatoprotection","volume":"29","author":"Il Gum","year":"2013","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.cbi.2025.111491_bib9","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1073\/pnas.081082098","article-title":"An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen","volume":"98","author":"Chan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2025.111491_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/epigenomes7040023","article-title":"Current approaches to epigenetic therapy","volume":"7","author":"Griazeva","year":"2023","journal-title":"Epigenomes"},{"key":"10.1016\/j.cbi.2025.111491_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.748449","article-title":"Role of BET proteins in inflammation and CNS diseases","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cbi.2025.111491_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2019.07.012","article-title":"Epigenetic pharmacotherapy for substance use disorder","volume":"168","author":"Sartor","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111491_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108306","article-title":"BET bromodomains as novel epigenetic targets for brain health and disease","volume":"181","author":"Singh","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2025.111491_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2025.111491_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111849","article-title":"The bromodomain and extra-terminal domain (BET) family: functional anatomy of BET paralogous proteins","volume":"17","author":"Taniguchi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2025.111491_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.modgep.2004.03.002","article-title":"Identification of unique, differentiation stage-specific patterns of expression of the bromodomain-containing genes Brd2, Brd3, Brd4, and Brdt in the mouse testis","volume":"4","author":"Shang","year":"2004","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.cbi.2025.111491_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2025.111491_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1006\/geno.1997.5000","article-title":"Identification and characterization of BRDT: a testis-specific gene related to the bromodomain genes RING3 and Drosophila fsh","volume":"45","author":"Jones","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.cbi.2025.111491_bib19","article-title":"The BET family in immunity and disease","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2025.111491_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115023","article-title":"Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injury","volume":"247","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111491_bib21","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1080\/21655979.2022.2066756","article-title":"Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis","volume":"13","author":"Fu","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.cbi.2025.111491_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/13543784.2023.2288075","article-title":"Gene expression inhibitors for the treatment of liver fibrosis: drugs under preclinical and early clinical investigation","volume":"32","author":"Ocker","year":"2023","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.cbi.2025.111491_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.toxlet.2023.08.009","article-title":"Bromodomain protein 4 mediates the roles of TGF\u03b21-induced Stat3 signaling in mouse liver fibrogenesis","volume":"385","author":"Xu","year":"2023","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2025.111491_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05328-7","article-title":"Targeting BRD4 mitigates hepatocellular lipotoxicity by suppressing the NLRP3 inflammasome activation and GSDMD-mediated hepatocyte pyroptosis","volume":"81","author":"Chen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2025.111491_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115497","article-title":"BRD4 promotes hepatic stellate cells activation and hepatic fibrosis via mediating P300\/H3K27ac\/PLK1 axis","volume":"210","author":"Cheng","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111491_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112281","article-title":"JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation","volume":"144","author":"Ding","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2025.111491_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7150\/ijms.29930","article-title":"MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation","volume":"16","author":"Huang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cbi.2025.111491_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109818","article-title":"Inhibitory effects of JQ1 on listeria monocytogenes-induced acute liver injury by blocking BRD4\/RIPK1 axis","volume":"125","author":"Qian","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2025.111491_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800007","article-title":"BET-Ting on Nrf2: how Nrf2 signaling can influence the therapeutic activities of BET protein inhibitors","volume":"40","author":"Chatterjee","year":"2018","journal-title":"Bioessays"},{"key":"10.1016\/j.cbi.2025.111491_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.157","article-title":"The bromodomain protein BRD4 regulates the KEAP1\/NRF2-dependent oxidative stress response","volume":"5","author":"Hussong","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2025.111491_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11040661","article-title":"BRD4 targets the KEAP1-nrf2-g6pd Axis and suppresses redox metabolism in small cell lung cancer","volume":"11","author":"Lv","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2025.111491_bib32","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.4049\/jimmunol.1301984","article-title":"Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression","volume":"192","author":"Michaeloudes","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cbi.2025.111491_bib33","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.gendis.2020.12.012","article-title":"BET bromodomain inhibitor JQ1 regulates spermatid development by changing chromatin conformation in mouse spermatogenesis","volume":"9","author":"Wang","year":"2021","journal-title":"Genes Dis"},{"key":"10.1016\/j.cbi.2025.111491_bib34","article-title":"BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2025.111491_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/cc.23309","article-title":"BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism","volume":"12","author":"Boehm","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cbi.2025.111491_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.09.003","article-title":"BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1\/Parkin-mediated mitophagy in vivo","volume":"149","author":"Mu","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2025.111491_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/toxsci\/kfu124","article-title":"Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes","volume":"141","author":"Rudraiah","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2025.111491_bib38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ajpath.2018.02.006","article-title":"Bromodomain and extraterminal (BET) proteins regulate hepatocyte proliferation in hepatocyte-driven liver regeneration","volume":"188","author":"Russell","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2025.111491_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12122055","article-title":"BET protein inhibitor JQ1 ameliorates experimental peritoneal damage by inhibition of inflammation and oxidative stress","volume":"12","author":"Marchant","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2025.111491_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcp.2015.01.013","article-title":"Role of nuclear factor-erythroid 2-related factor 2 (Nrf2) in the transcriptional regulation of brain ABC transporters during acute acetaminophen (APAP) intoxication in mice","volume":"94","author":"Ghanem","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111491_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s12192-015-0628-6","article-title":"Antioxidant fractions of Khaya grandifoliola C.DC. and Entada africana Guill. et Perr. induce nuclear translocation of Nrf2 in HC-04 cells","volume":"20","author":"Njayou","year":"2015","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.cbi.2025.111491_bib42","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.tiv.2007.05.003","article-title":"Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04","volume":"21","author":"Lim","year":"2007","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2025.111491_bib43","doi-asserted-by":"crossref","first-page":"15062","DOI":"10.1523\/JNEUROSCI.0826-15.2015","article-title":"Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity","volume":"35","author":"Sartor","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2025.111491_bib44","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111491_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2012.06.045","article-title":"Small-molecule inhibition of BRDT for male contraception","volume":"150","author":"Matzuk","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2025.111491_bib46","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation","volume":"122","author":"McGill","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2025.111491_bib47","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/dmd.124.001282","article-title":"Deciphering acetaminophen-induced hepatotoxicity: the crucial role of transcription factors like nuclear factor erythroid 2-related factor 2 as genetic determinants of susceptibility to drug-induced liver injury","volume":"52","author":"Laddha","year":"2024","journal-title":"Drug Metab. Dispos."},{"issue":"7 9","key":"10.1016\/j.cbi.2025.111491_bib48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cbi.2025.111491_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cells12172129","article-title":"Liver injury and regeneration: current understanding, new approaches, and future perspectives","volume":"12","author":"Hora","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2025.111491_bib50","doi-asserted-by":"crossref","first-page":"33766","DOI":"10.1074\/jbc.M504604200","article-title":"Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111491_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2016.01.004","article-title":"Protective effect of hyperoside against acetaminophen (APAP) induced liver injury through enhancement of APAP clearance","volume":"246","author":"Xie","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111491_bib52","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/dmd.121.000459","article-title":"Alterations of cytochrome P450-mediated drug metabolism during liver repair and regeneration after acetaminophen-induced liver injury in mice","volume":"50","author":"Bao","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2025.111491_bib53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/taap.1996.8009","article-title":"Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and the kidney","volume":"142","author":"Lind","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111491_bib54","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111491_bib55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-019-0030-7","article-title":"Bromodomains: a new target class for drug development","volume":"18","author":"Cochran","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2025.111491_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nbt.2776","article-title":"Genome-wide localization of small molecules","volume":"32","author":"Anders","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cbi.2025.111491_bib57","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.aaz8455","article-title":"Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation","volume":"368","author":"Gilan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cbi.2025.111491_bib58","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2025.111491_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1515\/DMDI.1988.6.3-4.413","article-title":"Mechanism of inhibition of hepatic bioactivation of paracetamol by dimethyl sulfoxide","volume":"6","author":"Jeffery","year":"1988","journal-title":"Drug Metabol. Drug Interact."},{"key":"10.1016\/j.cbi.2025.111491_bib60","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0041-008X(88)90048-8","article-title":"Protection by dimethylsulfoxide against acetaminophen-induced hepatic, but not respiratory toxicity in the mouse","volume":"93","author":"Jeffery","year":"1988","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111491_bib61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s43188-023-00180-6","article-title":"The Wnt\/\u03b2-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression","volume":"39","author":"Shin","year":"2023","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.cbi.2025.111491_bib62","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.110.035873","article-title":"Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes","volume":"39","author":"Guo","year":"2011","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.cbi.2025.111491_bib63","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1248\/bpb.b17-00913","article-title":"Comparison of drug metabolism and its related hepatotoxic effects in HepaRG, cryopreserved human hepatocytes, and HepG2 cell cultures","volume":"41","author":"Yokoyama","year":"2018","journal-title":"Biol. Pharm. Bull."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:53:34Z","timestamp":1744401214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725001218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":63,"alternative-id":["S0009279725001218"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111491","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of bromodomain and extra-terminal (BET) proteins with JQ1 exacerbates acetaminophen-induced hepatotoxicity by altering detoxification pathways and oxidative stress responses","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111491"}}